ANNUAL REPORT AND FINANCIAL STATEMENTS for the year ended 31 March 2017 MEDICLINIC ANNUAL REPORT 2017 1 SUB HEADING MEDICLINIC ANNUAL REPORT 2017 1 IFC Report Profile STRATEGIC REPORT 2 Performance Highlights  5 At a Glance 8 Chairman’s Statement 11 Chief Executive Officer’s Review 14 Financial Review 19 Five-Year Summary 20 Investment Case 21 Value Added Statement 22 Business Model 24 Our Strategy, Progress and Aims 30 Risk Management, Principal Risks   and Uncertainties 37 Clinical Services Overview 44 Divisional Review – Switzerland 47 Divisional Review – Southern Africa 50 Divisional Review – United Arab Emirates 54 Sustainable Development Highlights GOVERNANCE AND REMUNERATION 69 Chairman’s Introduction 70 Board of Directors 72 Senior Management 73 Corporate Governance Statement 85 Directors’ Remuneration Report 108 Nomination Committee Report 111 Clinical Performance and Sustainability   Committee Report 114 Audit and Risk Committee Report 123 Directors’ Report 129 Statement of Directors’ Responsibilities FINANCIAL STATEMENTS 130 Contents and General Information 131 Group Financial Statements 218 Company Financial Statements SHAREHOLDER INFORMATION 231 Shareholder Information 233 Company Information 234 Glossary 236 Forward-looking Statements CONTENTS FURTHER INFORMATION This Annual Report is published as part of a set of reports, as  listed below. The icons below are used as a cross-referencing  tool to refer to the relevant pages of these reports or within  this Annual Report. Annual Report and Financial Statements 2017  Clinical Services Report 2017  Sustainable Development Report 2017  Notice of Annual General Meeting 2017 These reports are available on the Company’s website at    from the date of distribution of this  Annual Report and the Company’s Notice of Annual General  Meeting by no later than 23 June 2017. APPROVAL OF ANNUAL REPORT This Annual Report and Financial Statements, including the  Strategic Report herein, were approved by the Disclosure  Committee, duly authorised by the Board, on 23 May 2017. Edwin Hertzog Non-executive Chairman 23 May 2017 AR CSR SDR AGM REPORT PROFILE AND CONTENTS REPORT PROFILE SCOPE, BOUNDARY AND  REPORTING CYCLE This Annual Report and Financial Statements (“Annual  Report”) of Mediclinic International plc (the “Company”  or “Mediclinic”) presents the financial results, and the  economic, social and environmental performance  of the Mediclinic Group for the financial year ended   31 March 2017 (the “reporting period”), and covers the  Company’s operations in Southern Africa, Switzerland  and the United Arab Emirates (the “Group”). REPORTING PRINCIPLES The information in this Annual Report is deemed to  be useful and relevant to our stakeholders, with due  regard to our stakeholders’ expectations through  continuous engagement, or that the Board believes  may influence the perception or decision-making of our  stakeholders. The information provided aims to provide  our stakeholders with an understanding of the Group’s  financial, social, environmental and economic impacts  to enable them to evaluate the ability of Mediclinic to  create and sustain value for our stakeholders. This Annual Report was prepared in accordance with  the International Financial Reporting Standards, the  LSE Listing Rules, the JSE Listings Requirements,  the UK Corporate Governance Code, and the UK   Companies Act (including the recently promulgated  Companies, Partnerships and Group (Accounts and  Non-Financial Reporting) Regulations 2016) aimed at  improving the transparency of companies regarding  non-financial and diversity information, where relevant. The Company applied the majority of the principles  contained in the UK Corporate Governance Code. Principles not applied are explained in the Corporate  Governance Statement, included in this Annual  Report..